Download PDFPDF
Risk of pancreatic adenocarcinoma in chronic pancreatitis
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Reply to Harlozinska-Szmirka et al
    • Philippe Ruszniewski, MD
    • Other Contributors:
      • David Malka, Pascal Hammel, Fédérique Maire, Pierre Rufat, Idalina Madeira, Fabienne Pessione, and Philippe Lévy

    Dear Editor

    In response to the letter addressed by Dr Harlozinska-Szmyrka we agree with the remarks made in relation to the difficulties in discrimination between chronic pancreatitis and adenocarcinoma using currently employed diagnostic imaging and tumour marker analysis. Our study aimed at determining risk of cancer development in patients with proven chronic pancreatitis,[1] examining age and sex standardised i...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    The diagnostic dilemmas in discrimination between pancreatic carcinoma and chronic pancreatitis

    Dear Editor

    Early diagnosis to distinguish between malignant pancreatic tumor and chronic pancreatitis is still difficult despite significant progress in imaging techniques. Moreover the patients with chronic pancreatitis are in a higher risk of pancreatic cancer development.

    The recently published study performed by Malka et al.[1] clearly confirms these difficulties independently of rigorous selection...

    Show More
    Conflict of Interest:
    None declared.